Product news

Share this article:
GlaxoSmithKline announced the approval of Requip XL(ropinirole extended-release tablets) in the US for the treatment of the signs and symptoms of idiopathic Parkinson's disease. The product should be available in pharmacies in mid-July 2008.
Share this article:
You must be a registered member of MMM to post a comment.

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.